Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells in Severe Pulmonary Emphysema
NCT01849159Phase 2Withdrawn
- Sponsor
- Federal Research Clinical Center of the FMBA
- Start
- Mar 2014
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in pulmonary emphysema, sponsored by Federal Research Clinical Center of the FMBA. Planned start Mar 2014; status: withdrawn.
02
Drugs
mesenchymal stem cells
03
Conditions
pulmonary emphysema
Beyond the preview
Go deeper on NCT01849159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849159.